Fulminant digital necrosis in a patient with prostate adenocarcinoma.
Paolini
M V
MV
Jankilevich
G
G
Graziano
C
C
Fernández Romero
D S
DS
D000230:Adenocarcinoma / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D004802:Eosinophilia / Q000209:etiology; D005385:Fingers / Q000098:blood supply* / Q000473:pathology; D006227:Hand Deformities, Acquired / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007511:Ischemia / Q000209:etiology*; D008297:Male; D009336:Necrosis; D020364:Paraneoplastic Polyneuropathy / Q000209:etiology; D010257:Paraneoplastic Syndromes / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D011471:Prostatic Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000209:etiology*
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal